Navigation Links
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Date:7/7/2011

octor decide how much Afinitor they need to take.

Afinitor may affect the way other medicines work, and other medicines can affect how Afinitor works. Using Afinitor with other medicines can cause serious side effects. Patients should tell their healthcare provider about all of the medicines they take, including prescription and non-prescription medicines, vitamins and herbal supplements such as: St. John's Wort, and medicine for fungal infections, bacterial infections, tuberculosis, seizures, HIV-AIDS, heart conditions or high blood pressure and medicines that suppress their immune system. Patients should not drink grapefruit juice or eat grapefruit during their treatment with Afinitor as it may make the amount of Afinitor in their blood increase to a harmful level.

Patients should not take Afinitor tablets which are broken or crushed. Patients should not chew or crush the tablets.

The amount of Afinitor in the blood was increased in patients who had liver problems.  Patients should tell their healthcare provider about all their medical conditions, including if they have or have had liver problems, diabetes or high blood sugar, high cholesterol levels, infections, hepatitis B or other medical conditions.

Patients should tell their healthcare provider if they are scheduled to receive any vaccinations. Patients should not receive a live vaccine or be around people who have recently received a live vaccine during treatment with Afinitor.

It is not known if Afinitor will harm an unborn baby. Women should use effective birth control while using Afinitor and for eight weeks after stopping treatment.

Common side effects of Afinitor in patients with advanced pancreatic neuroendocrine tumors include mouth ulcers, rash, diarrhea, swelling of arms, hands, feet, ankles, face or other parts of the body, abdominal pain, nausea, fever and headache. Common side effects of Afinitor in patients with advanced kidney cancer include mouth
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
2. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
3. Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
4. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
5. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
6. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
7. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
8. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
9. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
10. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
11. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The escalation ... proteins, is placing renewed emphasis on alternate delivery ... as a number of factors are converging to ... makers and their delivery device partners . These ... conditions, the growing trend toward self-administration for chronic ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
... 2011 Sanofi (EURONEXT: SAN and NYSE: ... of its dermatology business, Dermik, to Valeant Pharmaceuticals ... cash consideration of US $425 million. Valeant is ... dermatology therapeutic areas, based in Mississauga, Ontario, Canada. ...
... Pa., July 11, 2011 In a study sponsored ... company, scientists from the University of Massachusetts, Amherst presented ... was active against lice eggs from permethrin resistant head ... on Saturday, July 9, 2011 at the 37th ...
Cached Medicine Technology:Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc. 2Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc. 3Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc. 4Topaz Pharmaceuticals' Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs 2
(Date:5/19/2013)... Vegas Hotel Escapes, the premier Las ... launch it's all new vacation packages for the upcoming ... Consumers traveling to Las Vegas will be pleased to ... website. Travelers will be pleased to know that VegasHotelEscapes.com ... Vegas Hotel Escapes specializes in helping consumers Las ...
(Date:5/19/2013)... Beginning Wednesday, May 29 and running through ... will feature “Hot Dog Wednesdays" and Ice Cold Slushies at ... hot dogs and all the fixin's to donors on Wednesdays. ... the summer. “Donors are our lifeline. The summer months are ... blood supply. This is a small way for us ...
(Date:5/19/2013)... FL (PRWEB) May 19, 2013 The ... the website YazSideEffects.com in a concerted effort to connect ... the combination birth control drugs Yaz, Yasmin & Ocella ... a wealth of information on the notorious birth control ... against Bayer Pharmaceuticals. , Yaz, Yasmin & Ocella ...
(Date:5/18/2013)... The American Society for Gastrointestinal Endoscopy (ASGE) will honor ... ninth annual ASGE Crystal Awards on Sunday, May 19, ... year,s event will begin at ... Held in conjunction with Digestive Disease Week (DDW), the ... and scientific pursuit. The event will recognize the 2013 ...
(Date:5/18/2013)... Illuminations is proud to present the Inner ... will take place over the course of four days, on ... Saturday, June 8, 2013. , Inner Child Therapy is concerned ... the attitudes, patterns and coping mechanisms that create the behavior ... to live a more integrated and balanced life style, to ...
Breaking Medicine News(10 mins):Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7Health News:Illuminations Brings World Renowned Therapist to the Middle East 2
... a significant problem for American children, who miss about 1.6 million ... A new study published in the July issue of the journal ... of children have never seen a dentist and that disparities exist ... the duration between dental care visits. The study, ...
... Stone ... Showing a 9.9 Year Survival Rate. ,Success of Less Invasive Procedures for Knee ... ... 2010 -- Biologic knee repair, rather than bionic (artificial) replacement, may slow the progression ...
... -- Cosmetic contact lenses that give wearers an exaggerated ... among teenagers and young adults," the American Academy of ... "circle" lens extends beyond the iris and, in doing ... the young increased recently after pop star Lady Gaga ...
... ... the quality of family’s lives by providing the healthiest and most practical pool care ... and ultimately “greener” in nature. Pool Joe is determined to offer and encourage their ... , ...
... July 2010: Frontiers in Cardiovascular Biology ( ... organised by the Council on Basic Cardiovascular ... Society of Cardiology (ESC), is being held ... new European platform for the exchange of ...
... , ... Foundation Announced Today Construction of a State-of-the-Art Hospital in Rural Kenya. Founded by ... a Patient. The Foundation,s Investment Management Approach to African Philanthropy is a Departure ... ...
Cached Medicine News:Health News:1 in 4 Californian children have never seen a dentist, study finds 2Health News:Combination of Meniscus Allograft Transplantation and Repair of Articular Cartilage May Slow the Progression of Arthritis in the Knee 2Health News:Lady Gaga-Inspired Lens Fad Draws Warning From Eye Docs 2Health News:Los Angeles Pool Service Company Pool Joe is Going Organic using Eco-Safe Pool Products 2Health News:Frontiers in Cardiovascular Biology: July 16-19, 2010, Berlin, Germany 2Health News:State of the Art Hospital for Rural Kenya Announced by California Foundation 2Health News:State of the Art Hospital for Rural Kenya Announced by California Foundation 3
... Plus IgM Controls identify trends ... your ToRCH IgM immunoassay testing ... results. Liquichek ToRCH Plus IgM ... to Liquichek ToRCH Plus Controls ...
Each Liquichek Seroconversion Panel features a series of serum specimens drawn over time from one individual to show the progression from a negative to a positive disease state....
... are liquid controls designed to ... procedures that detect Chlamydia trachomatis ... are specimen specific, they can ... or endocervical/urethral swabs throughout the ...
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Medicine Products: